Geoffrey M. Parker occupies the position of Executive VP, Chief Financial & Accounting Officer at Allogene Therapeutics, Inc. Mr. Parker is also on the board of Perrigo Co. Plc, Better Therapeutics LLC and Better Therapeutics, Inc.

In the past Mr. Parker held the position of Chief Operating & Financial Officer, Executive VP at Tricida, Inc., Chief Financial Officer & Senior Vice President at Anacor, Inc., Partner at The Goldman Sachs Group, Inc., Vice President for Feibusch & Co., Inc., Chief Financial Officer & Executive Vice President of Anacor Pharmaceuticals LLC and Chief Business Officer of InteKrin Therapeutics, Inc.

He received an undergraduate degree from Dartmouth College and an MBA from Stanford Graduate School of Business.